Current status: 873 hESC lines, 3338 hiPSC lines, and 102 clinical studies, and 443 certificates
Monthly statistic from Nov 1, 2022
Posted on November 1, 2022
| total lines | 4211 |
| hESC lines | 873 |
| hiPSC lines | 3338 |
| derivation countries | 43 |
| projects | 248 |
| providers | 764 |
| clinical studies | 102 |
| subclones | 1784 |
| certificates | 443 |
| cell line certificates | 314 |
| project certificates | 129 |